Giadha A. DeCarcer, co-founding member of CTrust and founder of New Frontier Data, provides valuable insights into the cannabis markets in Europe and beyond. Europe's role in the global cannabis industry is still evolving, with Germany expected to play a deciding factor.

North America remains the epicenter of cannabis consumption and innovation, while Latin America is positioning itself as a trading hub for both the American and European markets. Asia Pacific is focused on medical research and development, particularly in Australia, and industrial hemp applications in China and Asia. Europe, as a potential large consumption market, has the opportunity to compete with American brands and become experts in processing technology.

African nations are also looking to meet European cannabis raw material demand. In terms of market segments, the medical segment is expected to dominate in Europe, with recreational users possibly transitioning into medical consumption. Industrial hemp's potential applications are vast and could impact sectors such as automotive and packaging.

The German medical market is experiencing a decline in patient counts after the introduction of adult use sales, although this varies by state and tax differentials. Overall, the global cannabis market is dynamic and intertwined, offering numerous opportunities for growth and collaboration